Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants
Clinical trial NCT06067568 · COMPLETED
Trial details
- NCT number
- NCT06067568
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2024-02-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.